Protein kinase B/Akt at a glance
Tóm tắt
Từ khóa
Tài liệu tham khảo
Alessi, D. R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice, N., Cohen, P. and Hemmings, B. A. (1996). Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J.15, 6541-6551.
Alessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R., Reese, C. B. and Cohen, P. (1997). Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr. Biol.7, 261-269.
Andjelkovic, M., Jakubowicz, T., Cron, P., Ming, X. F., Han, J. W. and Hemmings, B. A. (1996). Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. USA93, 5699-5704.
Andjelkovic, M., Maira, S. M., Cron, P., Parker, P. J. and Hemmings, B. A. (1999). Domain swapping used to investigate the mechanism of protein kinase B regulation by 3-phosphoinositide-dependent protein kinase 1 and Ser473 kinase. Mol. Cell. Biol.19, 5061-5072.
Arboleda, M. J., Lyons, J. F., Kabbinavar, F. F., Bray, M. R., Snow, B. E., Ayala, R., Danino, M., Karlan, B. Y. and Slamon, D. J. (2003). Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res.63, 196-206.
Balendran, A., Casamayor, A., Deak, M., Paterson, A., Gaffney, P., Currie, R., Downes, C. P. and Alessi, D. R. (1999). PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2. Curr. Biol.9, 393-404.
Barnett, S. F., Bilodeau, M. T. and Lindsley, C. W. (2005). The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation. Curr. Top. Med. Chem.5, 109-125.
Bernal-Mizrachi, E., Fatrai, S., Johnson, J. D., Ohsugi, M., Otani, K., Han, Z., Polonsky, K. S. and Permutt, M. A. (2004). Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells. J. Clin. Invest.114, 928-936.
Brazil, D. P. and Hemmings, B. A. (2001). Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem. Sci.26, 657-664.
Brazil, D. P., Park, J. and Hemmings, B. A. (2002). PKB binding proteins. Getting in on the Akt. Cell111, 293-303.
Brazil, D. P., Yang, Z. Z. and Hemmings, B. A. (2004). Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci.29, 233-242.
Chen, J., De, S., Damron, D. S., Chen, W. S., Hay, N. and Byzova, T. V. (2004). Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood104, 1703-1710.
Chen, W. S., Xu, P. Z., Gottlob, K., Chen, M. L., Sokol, K., Shiyanova, T., Roninson, I., Weng, W., Suzuki, R., Tobe, K. et al. (2001). Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev.15, 2203-2208.
Cho, H., Thorvaldsen, J. L., Chu, Q., Feng, F. and Birnbaum, M. J. (2001). Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J. Biol. Chem.276, 38349-38352.
Easton, R. M., Cho, H., Roovers, K., Shineman, D. W., Mizrahi, M., Forman, M. S., Lee, V. M., Szabolcs, M., de Jong, R., Oltersdorf, T. et al. (2005). Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol. Cell. Biol.25, 1869-1878.
Emamian, E. S., Hall, D., Birnbaum, M. J., Karayiorgou, M. and Gogos, J. A. (2004). Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet.36, 131-137.
Feng, J., Park, J., Cron, P., Hess, D. and Hemmings, B. A. (2004). Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J. Biol. Chem.279, 41189-41196.
Foster, F. M., Traer, C. J., Abraham, S. M. and Fry, M. J. (2003). The phosphoinositide (PI) 3-kinase family. J. Cell Sci.116, 3037-3040.
Gao, T., Furnari, F. and Newton, A. C. (2005). PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol. Cell18, 13-24.
Hanada, M., Feng, J. and Hemmings, B. A. (2004). Structure, regulation and function of PKB/AKT–a major therapeutic target. Biochim. Biophys. Acta1697, 3-16.
Huber, M., Helgason, C. D., Damen, J. E., Scheid, M., Duronio, V., Liu, L., Ware, M. D., Humphries, R. K. and Krystal, G. (1999). The role of SHIP in growth factor induced signalling. Prog. Biophys. Mol. Biol.71, 423-434.
Hutchinson, J. N., Jin, J., Cardiff, R. D., Woodgett, J. R. and Muller, W. J. (2004). Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. Cancer Res.64, 3171-3178.
Kawakami, Y., Nishimoto, H., Kitaura, J., Maeda-Yamamoto, M., Kato, R. M., Littman, D. R., Leitges, M., Rawlings, D. J. and Kawakami, T. (2004). Protein kinase C betaII regulates Akt phosphorylation on Ser-473 in a cell type- and stimulus-specific fashion. J. Biol. Chem.279, 47720-47725.
Lai, K. M., Gonzalez, M., Poueymirou, W. T., Kline, W. O., Na, E., Zlotchenko, E., Stitt, T. N., Economides, A. N., Yancopoulos, G. D. and Glass, D. J. (2004). Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol. Cell. Biol.24, 9295-9304.
Luo, J., Manning, B. D. and Cantley, L. C. (2003). Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell4, 257-262.
Luo, Y., Shoemaker, A. R., Liu, X., Woods, K. W., Thomas, S. A., de Jong, R., Han, E. K., Li, T., Stoll, V. S., Powlas, J. A. et al. (2005). Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo. Mol. Cancer Ther.6, 977-986.
Manning, G., Whyte, D. B., Martinez, R., Hunter, T. and Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science298, 1912-1934.
Nicholson, K. M. and Anderson, N. G. (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal.14, 381-395.
Ohba, N., Kiryu-Seo, S., Maeda, M., Muraoka, M., Ishii, M. and Kiyama, H. (2004). Transgenic mouse overexpressing the Akt reduced the volume of infarct area after middle cerebral artery occlusion. Neurosci. Lett.359, 159-162.
Peng, X. D., Xu, P. Z., Chen, M. L., Hahn-Windgassen, A., Skeen, J., Jacobs, J., Sundararajan, D., Chen, W. S., Crawford, S. E., Coleman, K. G. et al. (2003). Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev.17, 1352-1365.
Persad, S., Attwell, S., Gray, V., Mawji, N., Deng, J. T., Leung, D., Yan, J., Sanghera, J., Walsh, M. P. and Dedhar, S. (2001). Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinase activity and amino acids arginine 211 and serine 343. J. Biol. Chem.276, 27462-27469.
Sarbassov, D. D., Guertin, D. A., Ali, S. M. and Sabatini, D. M. (2005). Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science307, 1098-1101.
Schwertfeger, K. L., Richert, M. M. and Anderson S. M. (2001). Mammary gland involution is delayed by activated Akt in transgenic mice. Mol. Endocrinol.15, 867-881.
Schwertfeger, K. L., McManaman, J. L., Palmer, C. A., Neville, M. C. and Anderson, S. M. (2003). Expression of constitutively activated Akt in the mammary gland leads to excess lipid synthesis during pregnancy and lactation. J. Lipid Res.44, 1100-1112.
Song, G., Ouyang, G. and Bao, S. (2005). The activation of Akt/PKB signaling pathway and cell survival. J. Cell Mol. Med.9, 59-71.
Staal, S. P., Hartley, J. W. and Rowe, W. P. (1977). Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Natl. Acad. Sci. USA74, 3065-3067.
Stambolic, V., Suzuki, A., de la Pompa, J. L., Brothers, G. M., Mirtsos, C., Sasaki, T., Ruland, J., Penninger, J. M., Siderovski, D. P. and Mak, T. W. (1998). Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell95, 29-39.
Stephens, L., Anderson, K., Stokoe, D., Erdjument-Bromage, H., Painter, G. F., Holmes, A. B., Gaffney, P. R., Reese, C. B., McCormick, F., Tempst, P. et al. (1998). Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science279, 710-714.
Toker, A. and Newton, A. C. (2000). Akt/protein kinase B is regulated by autophosphorylation at the hypothetical PDK-2 site. J. Biol. Chem.275, 8271-8274.
Tschopp, O., Yang, Z. Z., Brodbeck, D., Dummler, B. A., Hemmings-Mieszczak, M., Watanabe, T., Michaelis, T., Frahm, J. and Hemmings, B. A. (2005). Essential role of protein kinase B{gamma} (PKB{gamma}/Akt3) in postnatal brain development but not in glucose homeostasis. Development132, 2943-2954.
Vanhaesebroeck, B. and Alessi, D. R. (2000). The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J.346, 561-576.
Viniegra, J. G., Martinez, N., Modirassari, P., Losa, J. H., Parada Cobo, C., Lobo, V. J., Luquero, C. I., Alvarez-Vallina, L., Ramon y Cajal, S., Rojas, J. M. et al. (2005). Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J. Biol. Chem.280, 4029-4036.
Whiteman, E. L., Cho, H. and Birnbaum, M. J. (2002). Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab.13, 444-451.
Woulfe, D., Jiang, H., Morgans, A., Monks, R., Birnbaum, M. and Brass, L. F. (2004). Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2. J. Clin. Invest.113, 441-450.
Wymann, M. P., Zvelebil, M. and Laffargue, M. (2003). Phosphoinositide 3-kinase signalling–which way to target? Trends Pharmacol. Sci.24, 366-376.
Yang, J., Cron, P., Good, V. M., Thompson, V., Hemmings, B. A. and Barford, D. (2002). Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP. Nat. Struct. Biol.12, 940-944.
Yang, Z. Z., Tschopp, O., Hemmings-Mieszczak, M., Feng, J., Brodbeck, D., Perentes, E. and Hemmings, B. A. (2003). Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J. Biol. Chem.278, 32124-32131.